Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Type I Diabetes I: Introduction

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Type I Diabetes III: Clinical Manifestations

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Genetic susceptibility shaped by biological state: beyond gene-environment interaction.

Frontiers in genetics·2026

Same author

SCOTCH: isoform-level characterization of gene expression through long-read single-cell RNA sequencing.

Nature communications·2026

Same author

Machine learning in prediction and classification of type 1 diabetes.

Nature genetics·2026

Same author

Redefining the role of the thiol-based agent <i>N</i>-acetylcysteine in human health and disease and elucidating potential advantages of its amide derivative.

RSC medicinal chemistry·2026

Same author

Convergent genetic pathways linking neuropsychiatric and ocular disorders in children.

Journal of child psychology and psychiatry, and allied disciplines·2026

Same author

Vascular malformations of the head and neck and a molecularly guided precision therapy framework.

Frontiers in neurology·2026

Search research articles

Related Experiment Video

Updated: Jul 14, 2026

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization

Published on: October 6, 2019

The IRF5 polymorphism in type 1 diabetes.

Hui-Qi Qu, Luc Marchand, Rosemary Grabs

Journal of Medical Genetics

|June 15, 2007

Summary

Functional variants in the interferon regulatory factor 5 gene (IRF5) are linked to autoimmune diseases. This study found no clear genetic link between IRF5 variations and type 1 diabetes (T1D) risk in families.

Area of Science:

Immunogenetics
Autoimmune Diseases
Molecular Biology

Background:

The interferon regulatory factor 5 (IRF5) gene is implicated in immune responses and autoimmune disorders like systemic lupus erythematosus (SLE).
Specific IRF5 genetic variants (SNPs) correlate with increased gene expression and SLE susceptibility.
The potential role of these functional IRF5 variants in other autoimmune conditions remains to be fully elucidated.

Purpose of the Study:

To investigate the association between functional IRF5 single nucleotide polymorphisms (SNPs), previously linked to SLE, and the risk of developing type 1 diabetes (T1D).

Main Methods:

Utilized the transmission disequilibrium test (TDT) in a cohort of 947 nuclear family trios.
Analyzed two specific IRF5 SNPs known to be correlated with IRF5 expression and SLE risk.

More Related Videos

Precise Visualization of Insulin Receptors A and B in Murine Brain with an RNA In Situ Hybridization Assay

Precise Visualization of Insulin Receptors A and B in Murine Brain with an RNA In Situ Hybridization Assay

Published on: July 15, 2025

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

Related Experiment Videos

Last Updated: Jul 14, 2026

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization

Published on: October 6, 2019

Precise Visualization of Insulin Receptors A and B in Murine Brain with an RNA In Situ Hybridization Assay

Precise Visualization of Insulin Receptors A and B in Murine Brain with an RNA In Situ Hybridization Assay

Published on: July 15, 2025

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Vasodilation of Isolated Vessels and the Isolation of the Extracellular Matrix of Tight-skin Mice

Published on: March 24, 2017

Main Results:

The study found no significant evidence to suggest that the functional IRF5 variations tested confer an obvious genetic risk for type 1 diabetes.
Transmission disequilibrium analysis did not reveal a strong association between the selected IRF5 SNPs and T1D in the analyzed family trios.

Conclusions:

Functional genetic variations in IRF5, while associated with SLE, do not appear to be a major predisposing factor for type 1 diabetes.
Further research may be needed to explore other potential genetic or environmental factors contributing to T1D pathogenesis.